Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

Trazodone For Sleep: Insomnia Treatment Guide For Adults Released

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Mission Connection has published a new guide on trazodone and its possible uses for sleep disorders.

-- Mission Connection has released a guide on trazodone, a medication that is sometimes prescribed off-label to treat sleep disorders. The resource covers applications, efficacy, and how the drug can be used safely to improve sleep quality.

For more information, please visit https://missionconnectionhealthcare.com/mental-health/sleep-aids/trazodone/

According to data from ClinCalc, trazodone was the 18th most prescribed drug in the United States in 2022, with over five million people filing a prescription for it in a single year. The drug is FDA-approved for use as an antidepressant, but because it can also alleviate insomnia, it is one of the most frequently prescribed sleep aids in the country.

As Mission Connection’s guide explains, trazodone belongs to a class of drugs known as serotonin antagonist and reuptake inhibitors (SARIs), which increase serotonin levels in the brain while blocking receptors that reabsorb the hormone. The drug also blocks 5-HT2A receptors, which can interrupt both non-REM and REM sleep; alpha-1 receptors, which are responsible for the fight or flight response; and H1 histamine receptors, which play a role in emotions and body temperature. The result is an overall calming effect that shifts the mind from a state of alertness to a state of rest; for this reason, it is particularly effective for users whose insomnia is caused by anxiety or depression.

Mission Connection’s guide says that trazodone is preferred by many because it is relatively inexpensive compared to brand-name sleep aids like Lunesta and Belsomra. Additionally, the drug causes fewer side effects than options like Ambien, meaning it is less likely to impair daily functioning. However, the resource notes that trazodone can still cause headaches, dizziness, daytime sleepiness, and orthostatic hypotension; it is also possible to overdose on the drug, resulting in potentially life-threatening conditions like serotonin syndrome and cardiac arrhythmias.

If dosed properly, trazodone can be used by adults struggling with insomnia to achieve restful sleep. However, Mission Connection’s guide notes that the drug is only a short-term solution for individuals whose sleep disturbances are caused by mental health conditions or chronic stress. For these cases, the resource advises readers to consider complementing trazodone with professional therapy programs to address the root causes of their sleep disorders.

More information is available at https://missionconnectionhealthcare.com/

Contact Info:
Name: Nathan Di Tomaso
Email: Send Email
Organization: Mission Connection
Address: 30310 Rancho Viejo Rd. , San Juan Capistrano, California 92675, United States
Website: https://missionconnectionhealthcare.com/

Source: PressCable

Release ID: 89195236

If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.17
+3.16 (1.39%)
AAPL  278.15
+3.00 (1.09%)
AMD  517.50
-15.08 (-2.83%)
BAC  57.88
-0.31 (-0.53%)
GOOG  336.71
-5.48 (-1.60%)
META  548.07
+5.20 (0.96%)
MSFT  365.04
+12.21 (3.46%)
NVDA  193.51
-2.23 (-1.14%)
ORCL  150.19
-2.27 (-1.49%)
TSLA  376.36
+1.24 (0.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.